Senti Biosciences Holdings, Inc.
SNTI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001854270
No open-market purchases or sales by Senti Biosciences Holdings, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $6.37M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Senti Biosciences Holdings, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −1 vs. Q1 2025
- Shares held
- 6.74M
- +821.2K (+13.9%) vs. Q1 2025
- Total value
- $14.2M
- −$5.66M (−28.5%) vs. Q1 2025
- New holders
- 1
- 5 more added
- Sold out
- 2
- 3 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNTI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $6.37M |
| Q1 2026 | 16 | $4.58M |
| Q4 2025 | 15 | $5.84M |
| Q3 2025 | 16 | $8.27M |
| Q2 2025 | 15 | $14.2M |
| Q1 2025 | 16 | $19.9M |
| Q4 2024 | 16 | $3.23M |
| Q3 2024 | 14 | $2.41M |
| Q2 2024 | 20 | $2.17M |
| Q1 2024 | 27 | $4.15M |
| Q4 2023 | 25 | $7.56M |
| Q3 2023 | 26 | $5.02M |
| Q2 2023 | 28 | $7.64M |
| Q1 2023 | 24 | $14.3M |
| Q4 2022 | 26 | $16.6M |
| Q3 2022 | 23 | $27.8M |
| Q2 2022 | 20 | $22.1M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Senti Biosciences Holdings, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 3,775,615 | $7.97M | 0.60% | 00.0% | Unchanged |
| Armistice Capital, LLC | 892,207 | $1.88M | 0.07% | +892,207 | New |
| Nantahala Capital Management, LLC | 888,000 | $1.87M | 0.13% | 00.0% | Unchanged |
| Heights Capital Management, Inc | 381,384 | $804.7K | 0.25% | −368,616−49.1% | Reduced |
| Vanguard Group Inc | 360,911 | $761.5K | 0.00% | +206,775+134.2% | Added |
| 8VC GP I, LLC | 253,755 | $535.4K | 0.53% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 147,314 | $310.8K | 0.00% | +117,588+395.6% | Added |
| BlackRock, Inc. | 22,084 | $46.6K | 0.00% | +18,080+451.5% | Added |
| State Street Corp | 10,010 | $21.1K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,412 | $9.31K | 0.00% | −39,072−89.9% | Reduced |
| Tower Research Capital LLC (TRC) | 1,121 | $2.37K | 0.00% | −304−21.3% | Reduced |
| Barclays PLC | 569 | $1.20K | 0.00% | +539+1,796.7% | Added |
| Bank of America Corp | 557 | $1.18K | 0.00% | +431+342.1% | Added |
| SBI Securities Co., Ltd. | 338 | $713 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 160 | $338 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −6,400−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −9−100.0% | Sold out |